The Efficacy Of percutaneous coronary intervention (PCI) on diastolic function in patients with coronary artery disease.

Comparative Survey of Left Ventricular Diastolic Function in CAD Patients Before and After PCI

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT201111238182N1

Enrollment

Registered

2011-12-01

Start date

2011-11-16

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart diastolic dysfunction. Other forms of heart disease

Interventions

Percutaneous coronary intervention.

Percutaneous coronary intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Pre PCI known CAD patients with any degree of diastolic dysfunction (grade 1 to 4) and LVEF>30% by echocardiography. Exclusion criteria: left ventricular hypertrophy (LVH) , uncontrolled hypertension (resting blood pressure>140/90 mm hg), Atrial fibrillation rhythm, hypertrophic cardiomyopathy, elevated Cr level, bundle branch or complete heart block, severe ventricular arrhythmias, severe valvular heart diseases, cardiac pacemakers and prior coronary artery bypass graft surgery

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Grade of diastolic dysfunction. Timepoint: before and three months after PCI. Method of measurement: By echocardiography.;DT. Timepoint: Before and three months after PCI. Method of measurement: By echocardiography.;IVRT. Timepoint: Before and three months after PCI. Method of measurement: By echocardiography.;E/A. Timepoint: Before and three months after PCI. Method of measurement: By echocardiography.;Mitral A duration /PVa duration. Timepoint: Before and three months after PCI. Method of measurement: By echocardiography.;PVs/PVd. Timepoint: Before and three months after PCI. Method of measurement: By echocardiography.;E/Ea. Timepoint: Before and three months after PCI. Method of measurement: By echocardiography.	—

Measure

Time frame

Grade of diastolic dysfunction. Timepoint: before and three months after PCI. Method of measurement: By echocardiography.;DT. Timepoint: Before and three months after PCI. Method of measurement: By echocardiography.;IVRT. Timepoint: Before and three months after PCI. Method of measurement: By echocardiography.;E/A. Timepoint: Before and three months after PCI. Method of measurement: By echocardiography.;Mitral A duration /PVa duration. Timepoint: Before and three months after PCI. Method of measurement: By echocardiography.;PVs/PVd. Timepoint: Before and three months after PCI. Method of measurement: By echocardiography.;E/Ea. Timepoint: Before and three months after PCI. Method of measurement: By echocardiography.

—

Secondary

Measure	Time frame
LVEF. Timepoint: Before And Three months after PCI. Method of measurement: By echocardiography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSayyid Mokhtar Javdan Nezhad

Kermanshah university of medical sciences and health services

sm.javdan@kums.ac.ir+98 83 1836 2022

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026